Journal of Capital Medical University ›› 2013, Vol. 34 ›› Issue (4): 601-604.doi: 10.3969/j.issn.1006-7795.2013.04.024

Previous Articles     Next Articles

Effect of individualized glycemic management on the prognosis of patients with severe cerebral hemorrhage

REN Tianhua1, SHI Hongmei2   

  1. 1. Department of Emergency, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China;
    2. Beijing Chongwen District Center for Disease Control and Prevention, Beijing 100050, China
  • Received:2013-05-08 Online:2013-08-21 Published:2013-07-20
  • Supported by:

    This study was supported by China Health and Medical Development Foundation(ZYYJJ201116).

Abstract:

Objective To evaluate the effect of individualized glycemic management on the prognosis of patients with severe cerebral hemorrhage. Methods Four hundred and fifty-one patients with severe cerebral hemorrhage(GCS score≤8) were randomly divided into two groups, to receive intensive insulin therapy or conventional insulin therapy. The mortality was observed in the 30th day after treatment. Results No significant difference in the mortality was found between the intensive insulin therapy group and conventional insulin therapy group(P>0.05). In 226 patients receiving intensive insulin treatment, a higher mortality was observed in patients with higher GHb(57.14% vs 40.63%, P=0.01). In 225 patients receiving conventional insulin treatment, a higher mortality was found in patients with normal GHb(49.65% vs 27.38%, P=0.001). Conclusion GHb should be tested in the patients with severe cerebral hemorrhage at admission, to provide information for adopting individualized glycemic management and setting glycemic control targets.

Key words: severe cerebral hemorrhage, glycemia, insulin, prognosis

CLC Number: